As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to European Commission in 2021 about ACRO Policy Recommendations for Guidance on Electronic Systems and Electronic Data in Clinical Trials can be found below.